Category Archives: Uncategorized

In latest from Trump Administration’s “deregulatory agenda,” hospitals are required to post prices and post meaningless gibberish

by Jeff Sovern So reports the NY Times. Excerpt: Vanderbilt University Medical Center, responding to a new Trump administration order to begin posting all hospital prices, listed a charge of $42,569 for a cardiology procedure described as “HC PTC CLOS PAT DUCT ART.” Baptist Health in Miami helpfully told consumers that an “Embolza Protect 5.5” […]

Shutdown impeding consumer and worker protections

In a post yesterday, Public Citizen reported that the government shutdown is placing crucial consumer, health, and safety protections at serious risk. The agency most impacted in the Consumer Product Safety Commission, where only 20 members of the 550-person staff are at work during the shutdown (working, but not being paid). For information about the […]

FTC during government shutdown

The following Federal Trade Commission services are NOT available during the shutdown: National Do Not Call Registry (For consumers) National Do Not Call Registry (For telemarketers) Consumer Sentinel Network (For law enforcement) Complaint Assistant (For filing consumer complaints) Identitytheft.gov (For consumers reporting ID theft) Econsumer.gov (For consumers reporting international complaints) Public comments can be submitted, […]

The Supreme Court unanimously rejects a “wholly groundless” exception to arbitrability under the Federal Arbitration Act

The Supreme Court today decided Henry Schein Inc. v. Archer and White Sales Inc., which presented the question "whether the Federal Arbitration Act permits a court to decline to enforce an agreement delegating questions of arbitrability to an arbitrator if the court concludes the claim of arbitrability is 'wholly groundless.'” The answer was an unanimous […]

Fosamax drug preemption case argued in the Supreme Court

The Supreme Court held argument yesterday in Merck Sharp & Dohme Corp. v. Albrecht. Here's the (loaded) question presented in Merck:  Whether a state-law failure-to-warn claim is pre-empted when the Food and Drug Administration rejected the drug manufacturer's proposal to warn about the risk after being provided with the relevant scientific data, or whether such a […]

“The FDA is still letting doctors implant untested devices into our bodies”

That's the name of this Washington Post article by Jeanne Lenzer and Shannon Brownlee. The article explains that the FDA continues to allow critical, implanted medical devices on the market via the so-called "510(k) process." Among other serious deficiencies, the 510(k) process does not require pre-market clinical safety testing. Lenzer and Brownlee explain that the […]

Applications for Janet D. Steiger Fellowship now open; it pays law students $6,000 to do summer consumer law work

Excerpts from the announcement: The Janet D. Steiger Fellowship Project provides law students the extraordinary opportunity to work in the consumer protection departments of state and territorial Offices of Attorneys General and other consumer protection agencies, including the National Association of Attorneys General and the Attorney General’s Office of the District of Columbia, throughout the […]

Judge Young Speaks His Mind About Arbitration

It could have been a routine order directing arbitration in a commercial dispute no one beyond the parties would likely care about. Instead, Judge William Young of the U.S. District Court for the District of Massachusetts used the occasion of a dispute between two companies about the meaning of their arbitration agreement to deliver an […]